Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doms

Showing results (281-290 of 335) with videos related to

Pageof 34
Sort By:
Journal of Virology|December 10, 1999
Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strainsH X Liao, B Etemad-Moghadam, D C Montefiori, et al.
Molecular Pharmacology|October 14, 2005
Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8Christopher A Haskell, Richard Horuk, Meina Liang, et al.
Journal of Virology|April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donorsAmandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2002
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kineticsJacqueline D Reeves, Stephen A Gallo, Navid Ahmad, et al.
Journal of Virology|July 5, 2007
Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonistsGeorge Lin, Andrea Bertolotti-Ciarlet, Beth Haggarty, et al.
Journal of Virology|August 13, 2010
A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5John C Tilton, Craig B Wilen, Chukwuka A Didigu, et al.
Virology|July 27, 1999
Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaquesZ Q Liu, S Muhkerjee, M Sahni, et al.
Blood|October 29, 2013
Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infectionChuka A Didigu, Craig B Wilen, Jianbin Wang, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
Hemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophagesJan Münch, Ludger Ständker, Stefan Pöhlmann, et al.
Journal of Virology|March 16, 2004
Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptorsStefan Pöhlmann, Carl Davis, Silke Meister, et al.
Pageof 34

Showing results (281-290 of 335) with videos related to

Sort By:
Pageof 34
Journal of Virology|December 10, 1999
Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strainsH X Liao, B Etemad-Moghadam, D C Montefiori, et al.
Molecular Pharmacology|October 14, 2005
Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8Christopher A Haskell, Richard Horuk, Meina Liang, et al.
Journal of Virology|April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donorsAmandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2002
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kineticsJacqueline D Reeves, Stephen A Gallo, Navid Ahmad, et al.
Journal of Virology|July 5, 2007
Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonistsGeorge Lin, Andrea Bertolotti-Ciarlet, Beth Haggarty, et al.
Journal of Virology|August 13, 2010
A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5John C Tilton, Craig B Wilen, Chukwuka A Didigu, et al.
Virology|July 27, 1999
Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaquesZ Q Liu, S Muhkerjee, M Sahni, et al.
Blood|October 29, 2013
Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infectionChuka A Didigu, Craig B Wilen, Jianbin Wang, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
Hemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophagesJan Münch, Ludger Ständker, Stefan Pöhlmann, et al.
Journal of Virology|March 16, 2004
Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptorsStefan Pöhlmann, Carl Davis, Silke Meister, et al.
Pageof 34